Table 3.
The mRNA expression of BARF1 and BHRF1 in cell lines before and after 5-Aza-CdR treatment.
| Cell line | Treatment | mRNA relative expression to GAPDH(2−ΔCt) | |
|---|---|---|---|
| BARF1 | BHRF1 | ||
| Raji | Untreated | 2.5 × 10−7 | 0.04 |
| 10 μmol/L 5-aza | 1.6 × 10−6 | 0.09 | |
| Ratio (after/before) | 6.4 | 2.3 | |
| B95-8 | Untreated | 0.30 | 0.23 |
| 10 μmol/L 5-aza | 0.64 | 0.78 | |
| Ratio (after/before) | 2.1 | 3.4 | |
| GT39 | Untreated | 6.4 × 10−4 | 2.4 × 10−4 |
| 10 μmol/L 5-aza | 1.6 × 10−3 | 4.0 × 10−3 | |
| Ratio (after/before) | 2.5 | 16.7 | |
| GT38 | Untreated | 6.7 × 10−3 | 0.04 |
| 10 μmol/L 5-aza | 0.49 | 0.26 | |
| Ratio (after/before) | 73.1 | 6.5 | |
| SNU719 | Untreated | 1.8 × 10−3 | 0.02 |
| 10 μmol/L 5-aza | 10.4 × 10−3 | 0.022 | |
| Ratio (after/before) | 5.8 | 1.1 | |